Kort beskrivelse
The Unit for Molecular Pathology will procure a sequencing platform (NGS) that can be used for mutation analyses of DNA and RNA for haematological neoplasia and solid growths, lung cancer, colorectal cancer, melanoma, sarcoma and other types of growth. The platforms must be suitable for the detection of SNV, splicing, copy number changes and RNA fusion transcripts. In the future the system will also be used for mutation analyses of cfDNA in plasma and MRD analyses.